Behavioral Insomnia Therapy for Fibromyalgia
Launched by DUKE UNIVERSITY · Nov 3, 1999
Trial Information
Current as of May 31, 2025
Completed
Keywords
ClinConnect Summary
Fibromyalgia (FM) is a prevalent and debilitating condition that contributes to impaired occupational and social functioning and increased disability among affected individuals. The vast majority of people with FM experience persistent sleep disturbances (e.g., onset difficulty, repeated or extended awakenings, nonrestorative sleep) that worsen other FM-related symptoms (e.g., chronic pain, fatigue) and sustain their general dysfunction. Pharmacologic treatments (e.g., antidepressants, hypnotics) may reduce symptoms for some people with FM, but many FM patients display little enduring impro...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Insomnia for more than 1 month
- • Fibromyalgia diagnosis
- • Participants must live within easy commuting distance of Duke Medical Center, Durham, North Carolina
- Exclusion Criteria:
- • Terminal illness
- • Major psychiatric disorder
- • Substance abuse
- • Dependence on hypnotic drugs
- • Other sleep disorders (sleep apnea, restless legs, etc.)
- • Other sleep-disturbing medical disorders (painful arthritis, thyroid condition, etc.)
About Duke University
Duke University, a leading academic and research institution located in Durham, North Carolina, is renowned for its commitment to advancing healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, Duke conducts a wide array of clinical trials aimed at developing cutting-edge therapies and improving patient outcomes across various medical fields. The university's Clinical Research Institute provides comprehensive support for trial design, implementation, and regulatory compliance, ensuring that all research adheres to the highest ethical and scientific standards. Duke’s dedication to translating research findings into effective clinical practices underscores its role as a pivotal contributor to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Durham, North Carolina, United States
Patients applied
Trial Officials
Jack D. Edinger, PhD
Principal Investigator
VA Medical Center-Durham
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials